MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
750.54%
Quick Ratio
750.54%
Cash Ratio
214.38%
Debt to Asset Ratio
21.93%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Marketable securities, non-curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
35,769
43,314
65,300
45,125
Marketable securities
80,569
98,165
131,147
163,805
Accounts receivable
2,932
1,494
1,761
3,186
Related party collaboration receivable
222
151
151
851
Prepaid expenses and other current assets
5,736
3,857
4,328
6,618
Total current assets
125,228
146,981
202,687
219,585
Property and equipment, net
11,194
12,218
13,136
13,291
Restricted cash
2,736
2,736
2,736
5,614
Marketable securities, non-current
32,476
30,181
5,244
20,081
Other non-current assets
214
-
-
-
Operating lease, right-of-use assets
25,905
27,209
28,478
29,740
Total assets
197,753
219,325
252,281
288,311
Accounts payable
1,614
2,723
5,013
2,116
Accrued expenses
7,951
6,972
12,098
14,953
Operating lease liabilities
6,876
7,363
7,840
7,848
Deferred revenue
244
395
1,590
10,578
Total current liabilities
16,685
17,453
26,541
35,495
Operating lease liabilities, net of current portion
25,691
27,203
28,659
30,520
Deferred revenue, net of current portion
-
-
-
1,471
Other non-current liabilities
1,000
1,000
1,000
1,000
Total liabilities
43,376
45,656
56,200
68,486
Common stock, 0.001 par value 240,000,000 and 120,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively 61,273,390 and 59,047,860 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
61
60
59
56
Additional paid-in capital
653,052
647,714
641,895
638,241
Accumulated other comprehensive (loss) income
-421
-263
32
7
Accumulated deficit
-498,315
-473,842
-445,905
-418,479
Total stockholders' equity
154,377
173,669
196,081
219,825
Total liabilities and stockholders' equity
197,753
219,325
252,281
288,311
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$80,569K (-53.06%↓ Y/Y)Cash and cashequivalents$35,769K (-18.60%↓ Y/Y)Prepaid expenses andother current assets$5,736K (-41.30%↓ Y/Y)Accounts receivable$2,932K (75.15%↑ Y/Y)Related partycollaboration receivable$222K (-73.91%↓ Y/Y)Total current assets$125,228K (-45.05%↓ Y/Y)Marketable securities,non-current$32,476K (-30.08%↓ Y/Y)Operating lease,right-of-use assets$25,905K (-16.36%↓ Y/Y)Property and equipment,net$11,194K (-19.58%↓ Y/Y)Restricted cash$2,736K (-4.80%↓ Y/Y)Other non-currentassets$214K Total assets$197,753K (-38.61%↓ Y/Y)Total liabilities andstockholders' equity$197,753K (-38.61%↓ Y/Y)Total stockholders'equity$154,377K (-36.72%↓ Y/Y)Total liabilities$43,376K (-44.50%↓ Y/Y)Accumulated deficit-$498,315K (-27.58%↓ Y/Y)Accumulated othercomprehensive (loss) income-$421K (-90.50%↓ Y/Y)Additional paid-in capital$653,052K (2.89%↑ Y/Y)Operating leaseliabilities, net of current...$25,691K (-21.11%↓ Y/Y)Total currentliabilities$16,685K (-60.26%↓ Y/Y)Other non-currentliabilities$1,000K (0.00%↑ Y/Y)Common stock, 0.001 parvalue 240,000,000 and...$61K (8.93%↑ Y/Y)Accrued expenses$7,951K (-33.88%↓ Y/Y)Operating leaseliabilities$6,876K (-9.96%↓ Y/Y)Accounts payable$1,614K (-10.53%↓ Y/Y)Deferred revenue$244K (-98.81%↓ Y/Y)

Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics, Inc. (VYGR)